| 注册
首页|期刊导航|中国医学创新|他汀类药物预防心肌梗死后房颤发生的临床研究

他汀类药物预防心肌梗死后房颤发生的临床研究

周志堂

中国医学创新Issue(15):81-82,83,3.
中国医学创新Issue(15):81-82,83,3.DOI:10.3969/j.issn.1674-4985.2014.15.029

他汀类药物预防心肌梗死后房颤发生的临床研究

Clinical Studies of Statins to Prevent Atrial Fibrillation after Myocardial Infarction

周志堂1

作者信息

  • 1. 广东省韶关市始兴县人民医院 广东 始兴 512500
  • 折叠

摘要

Abstract

Objective:To investigate the preventive effect of statins on atrial fibrillation after myocardial infarction. Method:80 patients with acute myocardial infarction from January 2012 to December 2013 in our hospital were selected, they were randomly divided into the statin group and the non-statin group according to the random number table method, 40 cases in each group.The statin group was given statins regularly before admission,the non-statin group wasn’t given statins before admission.The two groups underwent ECG monitoring,and the incidence of atrial fibrillation after myocardial infarction and the recurrent rate of paroxysmal atrial fibrillation of the two groups were observed and compared.Result:The incidence of atrial fibrillation of the statin group was 10.0%,it was significantly lower than 22.5%of the non-statin group,and the recurrence rate of paroxysmal atrial fibrillation of the statin group was 33.3%,it was significantly lower than 66.7%of the non-statin group,the differences were statistically significant(P<0.05).Conclusion:Statins can reduce the incidence of atrial fibrillation after MI,and conducive to the prevention of paroxysmal atrial fibrillation recur.It can effectively prevent the paroxysmal atrial fibrillation become permanent atrial fibrillation.

关键词

他汀类药物/心肌梗死/房颤

Key words

Statins/Myocardial infarction/Atrial fibrillation

引用本文复制引用

周志堂..他汀类药物预防心肌梗死后房颤发生的临床研究[J].中国医学创新,2014,(15):81-82,83,3.

基金项目

韶关市医学科研课题项目 ()

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文